HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 54 filers reported holding HARPOON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $383,826 | +95379.1% | 540,600 | 0.0% | 0.02% | -15.4% |
| Q1 2023 | $402 | +2.6% | 540,600 | 0.0% | 0.03% | 0.0% |
| Q4 2022 | $392 | -99.9% | 540,600 | 0.0% | 0.03% | -29.7% |
| Q3 2022 | $524,000 | -49.3% | 540,600 | 0.0% | 0.04% | -52.6% |
| Q2 2022 | $1,033,000 | -61.6% | 540,600 | 0.0% | 0.08% | -62.1% |
| Q1 2022 | $2,687,000 | -34.2% | 540,600 | 0.0% | 0.21% | -15.2% |
| Q4 2021 | $4,082,000 | -4.4% | 540,600 | 0.0% | 0.24% | +39.7% |
| Q3 2021 | $4,271,000 | -43.0% | 540,600 | 0.0% | 0.17% | -31.8% |
| Q2 2021 | $7,498,000 | -37.2% | 540,600 | -5.3% | 0.26% | -4.1% |
| Q1 2021 | $11,937,000 | +25.9% | 570,600 | 0.0% | 0.27% | +17.7% |
| Q4 2020 | $9,478,000 | -2.2% | 570,600 | 0.0% | 0.23% | -39.4% |
| Q3 2020 | $9,694,000 | -9.5% | 570,600 | -11.6% | 0.37% | -8.8% |
| Q2 2020 | $10,711,000 | +42.3% | 645,257 | -0.7% | 0.41% | +16.9% |
| Q1 2020 | $7,527,000 | -21.7% | 649,993 | -0.0% | 0.35% | -8.9% |
| Q4 2019 | $9,613,000 | +8.3% | 649,994 | 0.0% | 0.38% | -28.9% |
| Q3 2019 | $8,879,000 | +5.1% | 649,994 | 0.0% | 0.54% | +11.3% |
| Q2 2019 | $8,450,000 | +32.4% | 649,994 | -3.5% | 0.48% | +12.5% |
| Q1 2019 | $6,382,000 | – | 673,891 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |